Semaglutide comes in more than one formulation, and the differences matter. Some products are weekly injections; another is a daily tablet. They contain the same active drug but have different approved uses, dosing instructions, and practical considerations. Names matter. Ozempic and Wegovy are injectable products, while Rybelsus is taken by mouth. Their labels and indications are not interchangeable, so a clinician should guide treatment choices.
The phrase “Semaglutide Compound” can refer to a medication prepared by a compounding pharmacy rather than a manufacturer’s approved product. That distinction is easy to miss. Compounded medicines may be considered in specific circumstances, but they are not FDA-approved in the same way as branded products. Their ingredients, preparation, and labeling can differ. Products made with semaglutide salt forms, such as sodium or acetate, should not be assumed equivalent to semaglutide itself. Ask a licensed prescriber or pharmacist to clarify what a product contains and whether it is appropriate. This overview compares common semaglutide formulations and explains what to check before discussing treatment. It cannot determine which option is right for you. Even a familiar name deserves a closer look.
Semaglutide is the active compound in both oral tablets and subcutaneous injections. It belongs to a group of medicines called GLP-1 receptor agonists. By mimicking a gut hormone, it helps regulate blood glucose, supports insulin release when glucose is elevated, and slows stomach emptying. It can also influence appetite. The molecule is the same, but the delivery method changes how the body absorbs it. That detail matters.
Oral tablets pass through the digestive tract, where absorption can be limited. Some formulations include an absorption aid, and directions may require taking the tablet with a small amount of water before food or other medicines. Injectable formulations are given under the skin, commonly on a scheduled basis. Their dosing instructions and approved uses can differ. Do not switch between forms or adjust a dose without guidance from a qualified clinician. A clinician can consider the person’s health history, other medicines, and treatment goals. Responses vary, and nausea or other digestive effects may occur. The practical details are easy to underestimate. A prescription label and professional advice are more reliable than comparing doses online.
Injectable semaglutide is a prescription medicine given under the skin, usually once weekly. It is supplied in prefilled pens, but delivery details vary: some devices provide one dose, while others contain multiple doses. Pen design, dose increments, and preparation instructions are product-specific. These differences matter. Never assume that pens or instructions can be swapped.
Clinical evidence gives useful context. In the STEP 1 randomized trial, published in the New England Journal of Medicine, 1,961 adults with overweight or obesity received weekly semaglutide or placebo alongside lifestyle support. After 68 weeks, average body-weight change was −14.9% with semaglutide and −2.4% with placebo. This result describes a monitored study group, not a guaranteed individual outcome. The trial also reported gastrointestinal side effects, including nausea and diarrhea. (Wilding et al., NEJM, 2021.) The device may look simple. The dosing still deserves care.
Tips: Follow the specific product’s prescribing information and your clinician’s instructions. Check the dose window before injecting, rotate injection sites, and store the pen as directed. If the dose or device is unclear, pause and ask a pharmacist or prescriber rather than guessing.
Oral semaglutide is taken as a tablet once daily, usually at the start of the day. Swallow it whole with a small amount of plain water. Then wait at least 30 minutes before eating, drinking anything else, or taking other medicines. Timing matters. Coffee, breakfast, or a rushed morning can disrupt the routine, so a consistent reminder may help.
The tablet works by activating a receptor involved in blood sugar regulation and appetite. Its effects build over time; it is not a quick fix after one dose. Follow the prescribed dose and instructions, since different formulations may not be interchangeable. Nausea, diarrhea, constipation, or reduced appetite can occur, especially as treatment begins or the dose changes. Tell a healthcare professional about persistent symptoms, dehydration, or other medicines you take.
Daily tablets suit some people better than injections, though the fasting routine can feel fussy. That practical detail is easy to underestimate. Oral semaglutide is prescribed for specific medical needs, and suitability depends on a person’s health history and local product approval. A clinician can explain expected benefits, risks, and follow-up, including how blood glucose or side effects will be monitored.
| Formulation or Feature | Typical Details | How It Is Used | Key Considerations |
|---|---|---|---|
| Oral semaglutide tablets | Semaglutide is supplied as a tablet for once-daily oral use. Some formulations include an absorption-enhancing excipient such as sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC). | Designed to deliver semaglutide through the stomach after the tablet is swallowed. | Oral absorption is low and can vary; taking the tablet as directed is important. |
| 3 mg tablet strength | A commonly used starting strength in a standard oral dose-escalation schedule. | Typically taken once daily for the initial treatment period before increasing, if prescribed. | In the standard diabetes regimen, this starting strength is not considered a maintenance dose for blood-glucose control. |
| 7 mg tablet strength | A commonly used dose after the initial 3 mg period. | Taken once daily; a prescriber may maintain or adjust the dose according to response and tolerability. | Dose changes should follow the instructions for the specific product and jurisdiction. |
| 14 mg tablet strength | A higher commonly used daily strength in the standard oral diabetes regimen. | May be prescribed when additional treatment effect is needed and the lower dose is tolerated. | It is not appropriate for everyone; follow the prescribed dosing schedule. |
| Administration conditions | Take on an empty stomach with a small amount of plain water. Swallow the tablet whole. | Wait at least 30 minutes before eating, drinking anything other than water, or taking other oral medicines. | Food, beverages, or other medicines taken too soon can reduce absorption. |
| Dosing frequency | Once daily, preferably following the product’s specific instructions. | Take consistently; do not take extra tablets to make up for a missed dose unless instructed by a healthcare professional. | Daily oral dosing differs from once-weekly injectable semaglutide formulations. |
| Commonly reported side effects | Nausea, diarrhea, vomiting, constipation, and abdominal discomfort may occur. | Symptoms are often most noticeable when treatment begins or the dose increases. | Seek medical advice for severe or persistent symptoms or signs of a serious reaction. |
Note: Tablet strengths, approved uses, and dosing schedules can vary by product and country. This table is general educational information, not individualized medical advice; follow the local prescribing information and guidance from a qualified healthcare professional.
Compounded semaglutide may be discussed in two forms: semaglutide base and semaglutide salts, such as sodium or acetate. The base refers to semaglutide itself, the peptide used as the active ingredient in approved medicines. A salt form pairs semaglutide with another substance, changing its chemical form. The names can sound nearly interchangeable. They are not automatically equivalent.
That distinction matters. The U.S. Food and Drug Administration has cautioned that salt forms are different active ingredients and that their safety and effectiveness have not been established as equivalent to semaglutide base. A clear vial or familiar-looking label cannot show whether a preparation has the expected identity, strength, or quality. Those details require proper testing and reliable documentation.
Compounded products are not reviewed by the FDA for safety, effectiveness, and quality before marketing in the same way as approved medicines. Anyone considering one should ask a licensed clinician and pharmacist what form is being used, where it came from, and how it is measured and stored. Small differences in concentration can matter when doses are drawn into a syringe. That can feel like a technical detail, but it deserves a direct answer. If the ingredient is listed only as a salt, pause and seek qualified advice before using it.
Compounded semaglutide is discussed in base and salt forms. The chart compares each form with the active ingredient in FDA-approved semaglutide medicines.
“Yes” means the form is semaglutide base, the active ingredient in FDA-approved semaglutide medicines. FDA says semaglutide sodium and semaglutide acetate are different active ingredients and has stated it is not aware of a lawful basis for using these salt forms in compounding. This comparison does not mean compounded semaglutide products are FDA-approved. Source: U.S. FDA.
Semaglutide–B12 combinations pair semaglutide, a GLP-1 medicine, with vitamin B12, often in the form of cyanocobalamin. The exact ingredients and concentrations can vary between compounded preparations, so the product label matters. B12 supports normal nerve function and red blood cell production. Its presence does not, by itself, mean a combination works better for weight management. The NIH Office of Dietary Supplements sets the adult recommended allowance for B12 at 2.4 micrograms daily; that dietary reference is not an injectable dosing recommendation.
That distinction matters. Compounded combinations are not interchangeable with FDA-approved semaglutide products. The FDA has warned about dosing errors with compounded semaglutide, including errors requiring hospitalization; reports do not prove that every preparation caused harm. There is no established clinical evidence that adding B12 improves semaglutide-related weight loss or prevents nausea. Ask a qualified clinician or pharmacist to check the ingredient form, concentration, and dosing instructions. Read the label carefully. Confusing units can be easy, and that detail deserves attention.
It is usually injected under the skin once weekly. Follow your own prescription.
No. Some pens deliver one dose, while others contain several. Dose steps and preparation instructions can differ.
Check the dose window, rotate injection sites, and follow the product’s storage instructions. If anything seems unclear, pause and ask a pharmacist or prescriber.
Over 68 weeks, average body-weight change was −14.9% with semaglutide and −2.4% with placebo. Not a guarantee. The study included lifestyle support and monitoring.
Nausea and diarrhea were among the reported gastrointestinal side effects. Ask a clinician about symptoms that concern you.
No. Salt forms, such as sodium or acetate, are not automatically equivalent to semaglutide base. The names can sound deceptively similar.
Ask a licensed clinician or pharmacist about its ingredient form, source, strength, measurement, and storage. A clear vial does not confirm its contents or quality.
Small concentration differences can affect the amount drawn into a syringe. It is a technical detail, but guessing is not a safe shortcut.
Semaglutide is an active compound used in formulations designed for different routes of administration. Injectable formulations are generally taken once weekly and may differ in their delivery devices and dosing instructions. Oral formulations are taken daily as tablets, with directions for use that can affect how well the medicine is absorbed. These differences mean that injectable and oral products are not automatically interchangeable; dosing and use should be guided by a qualified healthcare professional.
A Semaglutide Compound may refer to a preparation containing semaglutide, but compounded forms can differ in their ingredients. Semaglutide base and semaglutide salt forms are not identical, so their composition and suitability should be confirmed with a healthcare professional. Some preparations also combine semaglutide with vitamin B12; this addition does not make B12 part of the semaglutide molecule. Understanding the active ingredient, formulation, and instructions is essential when comparing these types.